The First Take – Novartis sells Roche stake for big bucks
FirstTake on Pharma - Pharma News and Analysis Podcast
English - November 04, 2021 19:30 - 17 minutes - 11.8 MB - ★★★★★ - 2 ratingsScience pharma pharmaceutical intelligence firstword firsttake cardiovascular dermatology diabetes immunology infectious diseases Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: The First Take – Q3 earnings season kicks into gear
Next Episode: The First Take – Pfizer makes migraine move
FirstWord Pharma PLUS editors Virginia Li, Michael Flanagan and Simon King discuss Novartis’ $20 billion windfall from the sale of its 33% stake in crosstown rival Roche, Big Pharma’s increasing interest in protein degradation drugs, Pfizer’s eye-watering COVID-19 vaccine sales and survey results outlining a more complex path forward for Aduhelm than perhaps Biogen would like to admit.